James Murphy
Finanzdirektor/CFO bei MUSTANG BIO, INC.
Aktive Positionen von James Murphy
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MUSTANG BIO, INC. | Comptroller/Controller/Auditor | 19.01.2024 | - |
Finanzdirektor/CFO | 19.01.2024 | - |
Karriereverlauf von James Murphy
Ehemalige bekannte Positionen von James Murphy
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DECIBEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 07.10.2022 | 22.09.2023 |
Finanzdirektor/CFO | 07.10.2022 | 22.09.2023 | |
GI DYNAMICS, INC. | Finanzdirektor/CFO | 05.05.2016 | 01.12.2017 |
Unternehmenssekretär | 05.05.2016 | 01.12.2017 | |
Treasurer | 05.05.2016 | 01.12.2017 | |
ONCOTELIC THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 07.03.2011 | 29.12.2011 |
Finanzdirektor/CFO | 01.03.2004 | 31.03.2012 | |
Whatman, Inc.
Whatman, Inc. Industrial MachineryProducer Manufacturing Whatman, Inc. develops, manufactures, and markets separation technology devices. Its products are used for filtration, purification and storage of chemicals, and other liquids & samples. It is a subsidiary of Whatman Plc. The company was founded in 1961 and is headquartered in Florham Park, NJ. | Finanzdirektor/CFO | 01.01.2001 | 01.05.2003 |
HMSR, Inc.
HMSR, Inc. Medical SpecialtiesHealth Technology HMSR, Inc. developed products for blood transfusion and collection procedures. The company was founded by Eugene J. Zurlo and was headquartered in Boston, MA. | Comptroller/Controller/Auditor | 01.01.1994 | 01.01.2001 |
Finanzdirektor/CFO | 01.01.1994 | 01.01.2001 | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Comptroller/Controller/Auditor | 01.01.1990 | 01.01.1994 |
Ausbildung von James Murphy
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Director of Finance/CFO | 6 |
Comptroller/Controller/Auditor | 5 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Producer Manufacturing | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
DECIBEL THERAPEUTICS, INC. | Health Technology |
MUSTANG BIO, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Whatman, Inc.
Whatman, Inc. Industrial MachineryProducer Manufacturing Whatman, Inc. develops, manufactures, and markets separation technology devices. Its products are used for filtration, purification and storage of chemicals, and other liquids & samples. It is a subsidiary of Whatman Plc. The company was founded in 1961 and is headquartered in Florham Park, NJ. | Producer Manufacturing |
HMSR, Inc.
HMSR, Inc. Medical SpecialtiesHealth Technology HMSR, Inc. developed products for blood transfusion and collection procedures. The company was founded by Eugene J. Zurlo and was headquartered in Boston, MA. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
GI Dynamics, Inc.
GI Dynamics, Inc. Medical SpecialtiesHealth Technology GI Dynamics, Inc. engages in the development and commercialization of a medical device system intended for treatment of patients with type 2 diabetes and reduction of obesity. Its pipeline product is EndoBarrier, an endoscopically delivered medical device intended to help restore healthy blood sugar levels and reduce weight. The company was founded by Andy Levine on March 24, 2003 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- James Murphy
- Erfahrung